Pharmaceuticals
Company Overview of AbGenomics Corporation
Company Overview
AbGenomics Corporation engages in the discovery and development of therapeutic antibodies for immune-related inflammatory diseases and cancers. It develops therapeutic antibodies for the treatment of autoimmune diseases, allergy, asthma, transplantation rejection, and cancer. The company’s products include agonistic monoclonal antibodies, humanized monoclonal antibodies, enzyme controlling insulin sensitivity and lipid metabolism, and proteins. It also provides consulting services through its subsidiary. AbGenomics Corporation was founded in 2000 and is based in Taipei, Taiwan. AbGenomics Corporation operates as a subsidiary of AbGenomics International, Inc.
2F, No. 36, Lane. 358
Juikuang Road
Neihu
Taipei, 114
Taiwan
Founded in 2000
Key Executives for AbGenomics Corporation
Similar Private Companies By Industry
| Company Name | Region |
| Pharmaessentia Corporation | Asia |
| Akribio Co., Ltd. | Asia |
| Eli Lilly and Company (Taiwan), Inc. | Asia |
| Protech Pharmaservices Corporation | Asia |
| Panlabs Biologics Inc. | Asia |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| NYC2012, Inc. | United States |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| Rush University | United States |
| Greater Houston Partnership | United States |
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Ohio | Boehringer IngelheimPosted: May 05
- Gainesville, FL | AstraZenecaPosted: May 23
- Field, KY | Shire PharmaceuticalsPosted: May 18
Sponsored Financial Commentaries
Sponsored Links
To contact AbGenomics Corporation, please visit www.abgenomics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
